Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719095 · ClinicalTrials.gov registry record · Phase 2
Effective Treatment for Prescription Opioid Abuse
A Phase 2 study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00719095: Completed Phase 2 study, sponsored by University of Vermont Medical Center.
NCT00719095 is a Phase 2 study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 105 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00719095, a Phase 2 study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
There has been an alarming increase in abuse of prescription opioids in recent years. This project aims to develop an effective outpatient treatment for prescription opioid (PO) abuse that combines an intensive behavioral therapy with a pharmacotherapy regimen of buprenorphine detoxification and naltrexone maintenance.
Interventions
- BEHAVIORAL Behavioral therapy
- DRUG buprenorphine taper followed by naltrexone maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
What the finished NCT00719095 record still lists
NCT00719095 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral therapy is the first listed.
NCT00719095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00719095 about?
NCT00719095 is a clinical study titled "Effective Treatment for Prescription Opioid Abuse". There has been an alarming increase in abuse of prescription opioids in recent years. This project aims to develop an effective outpatient treatment for prescription opioid (PO) abuse that combines an intensive behavioral therapy with a pharmacotherapy regimen of buprenorphine detoxification and nal...
What is the current status of trial NCT00719095?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2006-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00719095?
The interventions under investigation include: Behavioral therapy (BEHAVIORAL), buprenorphine taper followed by naltrexone maintenance (DRUG).
Who is sponsoring clinical trial NCT00719095?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00719095's enrollment target sits among peer trials
105 650th of 2000 higher than 1,341 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia